Items where Author is "Kyriopoulos, I"

Number of items: 5.
  • Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece. Nomikos, N.; Naoum, P.; Athanasakis, Kostas; Kyriopoulos, I
  • Cost-effectiveness analysis of filgotinib versus tofacitinib as first-line treatments for rheumatoid arthritis in Greece. Nomikos, N.; Naoum, P.; Athanasakis, K.; Kyriopoulos, I
  • EE477 A budget impact analysis of introducing filgotinib for the treatment of rheumatoid arthritis in Greece. Nomikos, N.; Naoum, P.; Athanasakis, K.; Kyriopoulos, I
  • EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece. Nomikos, N.; Naoum, P.; Athanasakis, K.; Kyriopoulos, I
  • HPR240 A rapid review of key challenges and success factors in implementing managed entry agreements for pharmaceuticals:lessons for Greece. Zisis, K.; Karampli, E.; Nomikos, N.; Agorastos, I; Naoum, P.; Tsiantou, V; Kyriopoulos, I; Pavi, E.